Detection of simian immunodeficiency virus in semen, urethra, and male reproductive organs during efficient highly active antiretroviral therapy

Journal of Virology

Volumn 89, Issue 11, 2015, Pages 5772-5787

  Matusali, G ^a   Dereuddre Bosquet, N ^b,d,e   Le Tortorec, A ^a   Moreau, M ^a   Satie, A P ^a   Mahe D ^a   Roumaud, P ^a   Bourry, O ^a   Syll, N ^a,b,d,e   Bernard Stoecklin, S ^b,d,e   Pruvost, A ^c   Le Grand, R ^b,d,e   Dejucq Rainsford, N ^a  

^a UNIVERSITÉ DE RENNES 1   (France)

^b INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

^c SERVICE DE CHIMIE BIOORGANIQUE ET DE MARQUAGE   (France)

^d UNIVERSITÉ PARIS SACLAY   (France)

^e INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; EMTRICITABINE; LOPINAVIR; RALTEGRAVIR; RITONAVIR; TENOFOVIR; VIRUS DNA;

ADULT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG PENETRATION; DRUG TISSUE LEVEL; EPIDIDYMIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; MACACA; MALE; MALE GENITAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; PROSTATE; SEMEN ANALYSIS; SEMINAL VESICLE; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; SPERM; TESTIS; URETHRA; VIREMIA; VIROGENESIS; VIRUS DETECTION; VIRUS LOAD; VIRUS SHEDDING; ANIMAL; ISOLATION AND PURIFICATION; VIROLOGY;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; MACACA; SIMIAN IMMUNODEFICIENCY VIRUS;

ANIMALS; ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; GENITALIA, MALE; MACACA; MALE; SEMEN; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; URETHRA; VIRUS SHEDDING;

EID: 84929629839     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03628-14     Document Type: Article

References (105)

1. UNAIDS. 2013. Report on the global AIDS epidemic. UNAIDS, Geneva, Switzerland.
2. Baeten JM, Kahle E, Lingappa JR, Coombs RW, Delany-Moretlwe S, Nakku-Joloba E, Mugo NR, Wald A, Corey L, Donnell D, Campbell MS, Mullins JI, Celum C. 2011. Genital HIV-1 RNA predicts risk of heterosexual HIV-1 transmission. Sci Transl Med 3:77ra29. http://dx.doi.org/10.1126/scitranslmed.3001888.
3. European Study Group on Heterosexual Transmission of HIV. 1992. Comparison of female to male and male to female transmission of HIV in 563 stable couples. BMJ 304:809-813. http://dx.doi.org/10.1136/bmj.304.6830.809.
4. Padian NS, Shiboski SC, Glass SO, Vittinghoff E. 1997. Heterosexual transmission of human immunodeficiency virus (HIV) in northern California: results from a ten-year study. AmJ Epidemiol 146:350-357. http://dx.doi.org/10.1093/oxfordjournals.aje.a009276.
5. Baeten JM, Overbaugh J. 2003. Measuring the infectiousness of persons with HIV-1: opportunities for preventing sexual HIV-1 transmission. Curr HIV Res 1:69-86. http://dx.doi.org/10.2174/1570162033352110.
6. Sheth PM, Kovacs C, Kemal KS, Jones RB, Raboud JM, Pilon R, la Porte C, Ostrowski M, Loutfy M, Burger H, Weiser B, Kaul R. 2009. Persistent HIV RNA shedding in semen despite effective antiretroviral therapy. AIDS 23:2050-2054. http://dx.doi.org/10.1097/QAD.0b013e3283303e04.
7. Leruez-Ville M, Dulioust E, Costabliola D, Salmon D, Tachet A, Finkielsztejn L, De Almeida M, Silbermann B, Sicard D, Jouannet P, Rouzioux C. 2002. Decrease in HIV-1 seminal shedding in men receiving highly active antiretroviral therapy: an 18 month longitudinal study (ANRS EP012). AIDS 16:486-488. http://dx.doi.org/10.1097/00002030-200202150-00023.
8. Taylor S, Reynolds H, Sabin CA, Drake SM, White DJ, Back DJ, Pillay D. 2001. Penetration of efavirenz into the male genital tract: drug concentrations and antiviral activity in semen and blood of HIV-1-infected men. AIDS 15:2051-2053. http://dx.doi.org/10.1097/00002030-200110190-00022.
9. Gianella S, Smith DM, Vargas MV, Little SJ, Richman DD, Daar ES, Dube MP, Zhang F, Ginocchio CC, Haubrich RH, Morris SR. 2013. Shedding of HIV and human herpesviruses in the semen of effectively treated HIV-1-infected men who have sex with men. Clin Infect Dis 57:441-447. http://dx.doi.org/10.1093/cid/cit252.
10. Politch JA, Mayer KH, Welles SL, O'Brien WX, Xu C, Bowman FP, Anderson DJ. 2012. Highly active antiretroviral therapy does not completely suppress HIV in semen of sexually active HIV-infected men who have sex with men. AIDS 26:1535-1543. http://dx.doi.org/10.1097/QAD.0b013e328353b11b.
11. Galvin SR, Cohen MS. 2004. The role of sexually transmitted diseases in HIV transmission. Nat Rev Microbiol 2:33-42. http://dx.doi.org/10.1038/nrmicro794.
12. Ghosn J, Leruez-Ville M, Blanche J, Delobelle A, Beaudoux C, Mascard L, Lecuyer H, Canestri A, Landman R, Zucman D, Ponscarme D, Rami A, Viard JP, Spire B, Rouzioux C, Costagliola D, Suzan-Monti M. 2014. HIV-1 DNA levels in peripheral blood mononuclear cells and cannabis use are associated with intermittent HIV shedding in semen of men who have sex with men on successful antiretroviral regimens. Clin Infect Dis 58:1763-1770. http://dx.doi.org/10.1093/cid/ciu187.
13. Bunupuradah T, Bowonwattanuwong C, Jirajariyavej S, Munsakul W, Klinbuayaem V, Sophonphan J, Mahanontharit A, Hirschel B, Ruxrungtham K, Ananworanich J. 2014. HIV-1 genital shedding in HIVinfected patients randomized to second-line lopinavir/ritonavir monotherapy versus tenofovir/lamivudine/lopinavir/ritonavir. Antivir Ther 19:579-586. http://dx.doi.org/10.3851/IMP2737.
14. Osborne BJ, Sheth PM, Yi TJ, Kovacs C, Benko E, Porte C, Huibner S, Le AQ, Danroth R, Baraki B, Mazzulli T, Brumme ZL, Kaul R. 2013. Impact of antiretroviral therapy duration and intensification on isolated shedding of HIV-1 RNA in semen. J Infect Dis 207:1226-1234. http://dx.doi.org/10.1093/infdis/jit026.
15. Pasquier C, Moinard N, Saune K, Daudin M, Trancart S, Massip P, Izopet J, Bujan L. 2012. Antiviral effect of maraviroc in semen: a case report. Antivir Ther 17:933-936. http://dx.doi.org/10.3851/IMP2038.
16. Lambert-Niclot S, Tubiana R, Beaudoux C, Lefebvre G, Caby F, Bonmarchand M, Naouri M, Schubert B, Dommergues M, Calvez V, Flandre P, Poirot C, Marcelin AG. 2012. Detection of HIV-1 RNA in seminal plasma samples from treated patients with undetectable HIV-1 RNA in blood plasma on a 2002-2011 survey. AIDS 26:971-975. http://dx.doi.org/10.1097/QAD.0b013e328352ae09.
17. Halfon P, Giorgetti C, Khiri H, Penaranda G, Terriou P, Porcu-Buisson G, Chabert-Orsini V. 2010. Semen may harbor HIV despite effective HAART: another piece in the puzzle. PLoS One 5:e10569. http://dx.doi.org/10.1371/journal.pone.0010569.
18. Marcelin AG, Tubiana R, Lambert-Niclot S, Lefebvre G, Dominguez S, Bonmarchand M, Vauthier-Brouzes D, Marguet F, Mousset-Simeon N, Peytavin G, Poirot C. 2008. Detection of HIV-1 RNA in seminal plasma samples from treated patients with undetectable HIV-1 RNA in blood plasma. AIDS 22:1677-1679. http://dx.doi.org/10.1097/QAD.0b013e32830abdc8.
19. Pasquier CJ, Moinard N, Saune K, Souyris C, Lavit M, Daudin M, Izopet J, Bujan L. 2008. Persistent differences in the antiviral effects of highly active antiretroviral therapy in the blood and male genital tract. AIDS 22:1894-1896. http://dx.doi.org/10.1097/QAD.0b013e3283101281.
20. Houzet L, Matusali G, Dejucq-Rainsford N. 2014. Origins of HIVinfected leukocytes and virions in semen. J Infect Dis 210:S622-S630. http://dx.doi.org/10.1093/infdis/jiu328.
21. Coombs RW, Speck CE, Hughes JP, Lee W, Sampoleo R, Ross SO, Dragavon J, Peterson G, Hooton TM, Collier AC, Corey L, Koutsky L, Krieger JN. 1998. Association between culturable human immunodeficiency virus type 1 (HIV-1) in semen and HIV-1 RNA levels in semen and blood: evidence for compartmentalization of HIV-1 between semen and blood. J Infect Dis 177:320-330. http://dx.doi.org/10.1086/514213.
22. Chenine AL, Siddappa NB, Kramer VG, Sciaranghella G, Rasmussen RA, Lee SJ, Santosuosso M, Poznansky MC, Velu V, Amara RR, Souder C, Anderson DC, Villinger F, Else JG, Novembre FJ, Strobert E, O'Neil SP, Secor WE, Ruprecht RM. 2010. Relative transmissibility of an R5 clade C simian-human immunodeficiency virus across different mucosae in macaques parallels the relative risks of sexual HIV-1 transmission in humans via different routes. J Infect Dis 201:1155-1163. http://dx.doi.org/10.1086/651274.
23. Zhang H, Dornadula G, Beumont M, Livornese LJ, Van Uitert B, Henning K, Pomerantz RJ. 1998. Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy. N Engl J Med 339:1803-1809. http://dx.doi.org/10.1056/NEJM199812173392502.
24. Mayer KH, Boswell S, Goldstein R, Lo W, Xu C, Tucker L, DePasquale MP, D'Aquila R, Anderson DJ. 1999. Persistence of human immunodeficiency virus in semen after adding indinavir to combination antiretroviral therapy. Clin Infect Dis 28:1252-1259. http://dx.doi.org/10.1086/514775.
25. Nunnari G, Otero M, Dornadula G, Vanella M, Zhang H, Frank I, Pomerantz RJ. 2002. Residual HIV-1 disease in seminal cells of HIV-1-infected men on suppressive HAART: latency without on-going cellular infections. AIDS 16:39-45. http://dx.doi.org/10.1097/00002030-200201040-00006.
26. Craigo JK, Patterson BK, Paranjpe S, Kulka K, Ding M, Mellors J, Montelaro RC, Gupta P. 2004. Persistent HIV type 1 infection in semen and blood compartments in patients after long-term potent antiretroviral therapy. AIDS Res Hum Retroviruses 20:1196-1209. http://dx.doi.org/10.1089/aid.2004.20.1196.
27. Anderson DJ, Politch JA, Nadolski AM, Blaskewicz CD, Pudney J, Mayer KH. 2010. Targeting Trojan horse leukocytes for HIV prevention. AIDS 24:163-187. http://dx.doi.org/10.1097/QAD.0b013e32833424c8.
28. Salle B, Brochard P, Bourry O, Mannioui A, Andrieu T, Prevot S, Dejucq-Rainsford N, Dereuddre-Bosquet N, Le Grand R. 2010. Infection of macaques after vaginal exposure to cell-associated simian immunodeficiency virus. J Infect Dis 202:337-344. http://dx.doi.org/10.1086/653619.
29. Bernard-Stoecklin S, Gommet C, Corneau AB, Guenounou S, Torres C, Dejucq-Rainsford N, Cosma A, Dereuddre-Bosquet N, Le Grand R. 2013. Semen CD4(+) T cells and macrophages are productively infected at all stages of SIV infection in macaques. PLoS Pathog 9:e1003810. http://dx.doi.org/10.1371/journal.ppat.1003810.
30. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Hakim JG, Kumwenda J, Grinsztejn B, Pilotto JH, Godbole SV, Mehendale S, Chariyalertsak S, Santos BR, Mayer KH, Hoffman IF, Eshleman SH, Piwowar-Manning E, Wang L, Makhema J, Mills LA, de Bruyn G, Sanne I, Eron J, Gallant J, Havlir D, Swindells S, Ribaudo H, Elharrar V, Burns D, Taha TE, Nielsen-Saines K, Celentano D, Essex M, Fleming TR. 2011. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 365:493-505. http://dx.doi.org/10.1056/NEJMoa1105243.
31. Donnell D, Baeten JM, Kiarie J, Thomas KK, Stevens W, Cohen CR, McIntyre J, Lingappa JR, Celum C. 2010. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet 375:2092-2098. http://dx.doi.org/10.1016/S0140-6736(10)60705-2.
32. Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, Wabwire-Mangen F, Meehan MO, Lutalo T, Gray RH. 2000. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group.NEngl J Med 342:921-929. http://dx.doi.org/10.1056/NEJM200003303421303.
33. Baggaley RF, White RG, Boily MC. 2010. HIV transmission risk through anal intercourse: systematic review, meta-analysis and implications for HIV prevention. Int J Epidemiol 39:1048-1063. http://dx.doi.org/10.1093/ije/dyq057.
34. Jin F, Jansson J, Law M, Prestage GP, Zablotska I, Imrie JC, Kippax SC, Kaldor JM, Grulich AE, Wilson DP. 2010. Per-contact probability of HIV transmission in homosexual men in Sydney in the era of HAART. AIDS 24:907-913. http://dx.doi.org/10.1097/QAD.0b013e3283372d90.
35. Rodger A, Bruun T, Cambiano V, Vernazza P, Estrada V, Van Lunzen J, Collins S, Geretti A-M, Phillips A, Lundgren J. 2014. HIV transmission risk through condomless sex if HIV+ partner on suppressive ART: PARTNER Study, abstr 153LB. Abstr Conf Retroviruses Opportunistic Infect. CROI 2014, Boston, MA.
36. Sturmer M, Doerr HW, Berger A, Gute P. 2008. Is transmission of HIV-1 in non-viraemic serodiscordant couples possible? Antivir Ther 13:729-732.
37. Lu W, Zeng G, Luo J, Duo S, Xing G, Guo-Wei D, Jian-Ping Z, Wen-Sheng H, Ning W. 2010. HIV transmission risk among serodiscordant couples: a retrospective study of former plasma donors in Henan, China. J Acquir Immune Defic Syndr 55:232-238. http://dx.doi.org/10.1097/QAI.0b013e3181e9b6b7.
38. Bezemer D, de Wolf F, Boerlijst MC, van Sighem A, Hollingsworth TD, Prins M, Geskus RB, Gras L, Coutinho RA, Fraser C. 2008. A resurgent HIV-1 epidemic among men who have sex with men in the era of potent antiretroviral therapy. AIDS 22:1071-1077. http://dx.doi.org/10.1097/QAD.0b013e3282fd167c.
39. Anderson JA, Ping LH, Dibben O, Jabara CB, Arney L, Kincer L, Tang Y, Hobbs M, Hoffman I, Kazembe P, Jones CD, Borrow P, Fiscus S, Cohen MS, Swanstrom R. 2010. HIV-1 populations in semen arise through multiple mechanisms. PLoS Pathog 6:e1001053. http://dx.doi.org/10.1371/journal.ppat.1001053.
40. Pillai SK, Good B, Pond SK, Wong JK, Strain MC, Richman DD, Smith DM. 2005. Semen-specific genetic characteristics of human immunodeficiency virus type 1 env. J Virol 79:1734-1742. http://dx.doi.org/10.1128/JVI.79.3.1734-1742.2005.
41. Ghosn J, Viard JP, Katlama C, de Almeida M, Tubiana R, Letourneur F, Aaron L, Goujard C, Salmon D, Leruez-Ville M, Rouzioux C, Chaix ML. 2004. Evidence of genotypic resistance diversity of archived and circulating viral strains in blood and semen of pre-treated HIV-infected men. AIDS 18:447-457. http://dx.doi.org/10.1097/00002030-200402200-00011.
42. Whitney JB, Hraber PT, Luedemann C, Giorgi EE, Daniels MG, Bhattacharya T, Rao SS, Mascola JR, Nabel GJ, Korber BT, Letvin NL. 2011. Genital tract sequestration of SIV following acute infection. PLoS Pathog 7:e1001293. http://dx.doi.org/10.1371/journal.ppat.1001293.
43. Deleage C, Moreau M, Rioux-Leclercq N, Ruffault A, Jegou B, Dejucq-Rainsford N. 2011. Human immunodeficiency virus infects human seminal vesicles in vitro and in vivo. Am J Pathol 179:2397-2408. http://dx.doi.org/10.1016/j.ajpath.2011.08.005.
44. Le Tortorec A, Le Grand R, Denis H, Satie AP, Mannioui K, Roques P, Maillard A, Daniels S, Jegou B, Dejucq-Rainsford N. 2008. Infection of semen-producing organs by SIV during the acute and chronic stages of the disease. PLoS One 3:e1792. http://dx.doi.org/10.1371/journal.pone.0001792.
45. Paranjpe S, Craigo J, Patterson B, Ding M, Barroso P, Harrison L, Montelaro R, Gupta P. 2002. Subcompartmentalization of HIV-1 quasispecies between seminal cells and seminal plasma indicates their origin in distinct genital tissues. AIDS Res Hum Retroviruses 18:1271-1280. http://dx.doi.org/10.1089/088922202320886316.
46. Roulet V, Satie AP, Ruffault A, Le Tortorec A, Denis H, Guist'hau O, Patard JJ, Rioux-Leclerq N, Gicquel J, Jegou B, Dejucq-Rainsford N. 2006. Susceptibility of human testis to human immunodeficiency virus-1 infection in situ and in vitro. Am J Pathol 169:2094-2103. http://dx.doi.org/10.2353/ajpath.2006.060191.
47. Shehu-Xhilaga M, Kent S, Batten J, Ellis S, Van der Meulen J, O'Bryan M, Cameron PU, Lewin SR, Hedger MP. 2007. The testis and epididymis are productively infected by SIV and SHIV in juvenile macaques during the post-acute stage of infection. Retrovirology 4:7. http://dx.doi.org/10.1186/1742-4690-4-7.
48. National Institutes of Health. 2002. Public Health Service policy on humane care and use of laboratory animals. Office of Laboratory Animal Welfare, National Institutes of Health, Bethesda, MD.
49. European Union. 20 October 2010. Directive 2010/63/EU of the European Parliament and of the Council of 22 September 2010 on the protection of animals used for scientific purposes. Official J Eur Union 53:L276. http://dx.doi.org/10.3000/17252555.L_2010.276.eng.
50. Dioszeghy V, Benlhassan-Chahour K, Delache B, Dereuddre-Bosquet N, Aubenque C, Gras G, Le Grand R, Vaslin B. 2006. Changes in soluble factor-mediated CD8+ cell-derived antiviral activity in cynomolgus macaques infected with simian immunodeficiency virus SIVmac251: relationship to biological markers of progression. J Virol 80: 236-245. http://dx.doi.org/10.1128/JVI.80.1.236-245.2006.
51. North TW, Higgins J, Deere JD, Hayes TL, Villalobos A, Adamson L, Shacklett BL, Schinazi RF, Luciw PA. 2010. Viral sanctuaries during highly active antiretroviral therapy in a nonhuman primate model for AIDS. J Virol 84:2913-2922. http://dx.doi.org/10.1128/JVI.02356-09.
52. Pasternak AO, Adema KW, Bakker M, Jurriaans S, Berkhout B, Cornelissen M, Lukashov VV. 2008. Highly sensitive methods based on seminested real-time reverse transcription-PCR for quantitation of human immunodeficiency virus type 1 unspliced and multiply splicedRNA and proviral DNA. J Clin Microbiol 46:2206-2211. http://dx.doi.org/10.1128/JCM.00055-08.
53. Moreau M, Le Tortorec A, Deleage C, Brown C, Denis H, Satie AP, Bourry O, Deureuddre-Bosquet N, Roques P, Le Grand R, Dejucq-Rainsford N. 2012. Impact of short-term HAART initiated during the chronic stage or shortly post-exposure on SIV infection of male genital organs. PLoS One 7:e37348. http://dx.doi.org/10.1371/journal.pone.0037348.
54. Mannioui A, Bourry O, Sellier P, Delache B, Brochard P, Andrieu T, Vaslin B, Karlsson I, Roques P, Le Grand R. 2009. Dynamics of viral replication in blood and lymphoid tissues during SIVmac251 infection of macaques. Retrovirology 6:106. http://dx.doi.org/10.1186/1742-4690-6-106.
55. Nishimura M, Naito S. 2005. Tissue-specific mRNA expression profiles of human toll-like receptors and related genes. Biol Pharm Bull 28:886-892. http://dx.doi.org/10.1248/bpb.28.886.
56. Keele BF, Li H, Learn GH, Hraber P, Giorgi EE, Grayson T, Sun C, Chen Y, Yeh WW, Letvin NL, Mascola JR, Nabel GJ, Haynes BF, Bhattacharya T, Perelson AS, Korber BT, Hahn BH, Shaw GM. 2009. Low-dose rectal inoculation of rhesus macaques by SIVsmE660 or SIVmac251 recapitulates human mucosal infection by HIV-1. J Exp Med 206:1117-1134. http://dx.doi.org/10.1084/jem.20082831.
57. Hirsch V, Adger-Johnson D, Campbell B, Goldstein S, Brown C, Elkins WR, Montefiori DC. 1997. A molecularly cloned, pathogenic, neutralization-resistant simian immunodeficiency virus, SIVsmE543-3. J Virol 71:1608-1620.
58. Brown CR, Czapiga M, Kabat J, Dang Q, Ourmanov I, Nishimura Y, Martin MA, Hirsch VM. 2007. Unique pathology in simian immunodeficiency virus-infected rapid progressor macaques is consistent with a pathogenesis distinct from that of classical AIDS. J Virol 81:5594-5606. http://dx.doi.org/10.1128/JVI.00202-07.
59. Fletcher CV, Staskus K, Wietgrefe SW, Rothenberger M, Reilly C, Chipman JG, Beilman GJ, Khoruts A, Thorkelson A, Schmidt TE, Anderson J, Perkey K, Stevenson M, Perelson AS, Douek DC, Haase AT, Schacker TW. 2014. Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues. Proc Natl Acad Sci U S A 111:2307-2312. http://dx.doi.org/10.1073/pnas.1318249111.
60. Applied Biosystems. 2001. ABI Prism 7700 sequence detection system. User bulletin 2. Applied Biosystems, Foster City, CA.
61. Buzon MJ, Massanella M, Llibre JM, Esteve A, Dahl V, Puertas MC, Gatell JM, Domingo P, Paredes R, Sharkey M, Palmer S, Stevenson M, Clotet B, Blanco J, Martinez-Picado J. 2010. HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAARTsuppressed subjects. Nat Med 16:460-465. http://dx.doi.org/10.1038/nm.2111.
62. Markowitz M, Nguyen BY, Gotuzzo E, Mendo F, Ratanasuwan W, Kovacs C, Prada G, Morales-Ramirez JO, Crumpacker CS, Isaacs RD, Gilde LR, Wan H, Miller MD, Wenning LA, Teppler H. 2007. Rapid and durable antiretroviral effect of the HIV-1 integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection: results of a 48-week controlled study. J Acquir Immune Defic Syndr 46:125-133. http://dx.doi.org/10.1097/QAI.0b013e318157131c.
63. Lewis MG, Norelli S, Collins M, Barreca ML, Iraci N, Chirullo B, Yalley-Ogunro J, Greenhouse J, Titti F, Garaci E, Savarino A. 2010. Response of a simian immunodeficiency virus (SIVmac251) to raltegravir: a basis for a new treatment for simian AIDS and an animal model for studying lentiviral persistence during antiretroviral therapy. Retrovirology 7:21. http://dx.doi.org/10.1186/1742-4690-7-21.
64. Mavigner M, Watkins B, Lawson B, Lee ST, Chahroudi A, Kean L, Silvestri G. 2014. Persistence of virus reservoirs in ART-treated SHIVinfected rhesus macaques after autologous hematopoietic stem cell transplant. PLoS Pathog 10:e1004406. http://dx.doi.org/10.1371/journal.ppat.1004406.
65. Deere JD, Higgins J, Cannavo E, Villalobos A, Adamson L, Fromentin E, Schinazi RF, Luciw PA, North TW. 2010. Viral decay kinetics in the highly active antiretroviral therapy-treated rhesus macaque model of AIDS. PLoS One 5:e11640. http://dx.doi.org/10.1371/journal.pone.0011640.
66. Zink MC, Brice AK, Kelly KM, Queen SE, Gama L, Li M, Adams RJ, Bartizal C, Varrone J, Rabi SA, Graham DR, Tarwater PM, Mankowski JL, Clements JE. 2010. Simian immunodeficiency virus-infected macaques treated with highly active antiretroviral therapy have reduced central nervous system viral replication and inflammation but persistence of viral DNA. J Infect Dis 202:161-170. http://dx.doi.org/10.1086/653213.
67. Dinoso JB, Rabi SA, Blankson JN, Gama L, Mankowski JL, Siliciano RF, Zink MC, Clements JE. 2009. A simian immunodeficiency virusinfected macaque model to study viral reservoirs that persist during highly active antiretroviral therapy. J Virol 83:9247-9257. http://dx.doi.org/10.1128/JVI.00840-09.
68. Gordon SN, Dunham RM, Engram JC, Estes J, Wang Z, Klatt NR, Paiardini M, Pandrea IV, Apetrei C, Sodora DL, Lee HY, Haase AT, Miller MD, Kaur A, Staprans SI, Perelson AS, Feinberg MB, Silvestri G. 2008. Short-lived infected cells support virus replication in sooty mangabeys naturally infected with simian immunodeficiency virus: implications for AIDS pathogenesis. J Virol 82:3725-3735. http://dx.doi.org/10.1128/JVI.02408-07.
69. Else LJ, Taylor S, Back DJ, Khoo SH. 2011. Pharmacokinetics of antiretroviral drugs in anatomical sanctuary sites: the male and female genital tract. Antivir Ther 16:1149-1167. http://dx.doi.org/10.3851/IMP1919.
70. Chan DJ, Ray JE. 2007. Quantification of antiretroviral drugs for HIV-1 in the male genital tract: current data, limitations and implications for laboratory analysis. J Pharm Pharmacol 59:1451-1462. http://dx.doi.org/10.1211/jpp.59.11.0001.
71. Calcagno A, Bonora S, D'Avolio A, Siccardi M, Simiele M, Chiesa M, Gonzalez de Requena D, Perri GD. 2010. Raltegravir penetration in seminal plasma of healthy volunteers. Antimicrob Agents Chemother 54:2744-2745. http://dx.doi.org/10.1128/AAC.00241-10.
72. Lorello G, la Porte C, Pilon R, Zhang G, Karnauchow T, MacPherson P. 2009. Discordance in HIV-1 viral loads and antiretroviral drug concentrations comparing semen and blood plasma. HIV Med 10:548-554. http://dx.doi.org/10.1111/j.1468-1293.2009.00725.x.
73. Patterson KB, Prince HA, Kraft E, Jenkins AJ, Shaheen NJ, Rooney JF, Cohen MS, Kashuba AD. 2011. Penetration of tenofovir and emtricitabine in mucosal tissues: implications for prevention of HIV-1 transmission. Sci Transl Med 3:112re114. http://dx.doi.org/10.1126/scitranslmed.3003174.
74. Dumond JB, Patterson KB, Pecha AL, Werner RE, Andrews E, Damle B, Tressler R, Worsley J, Kashuba AD. 2009. Maraviroc concentrates in the cervicovaginal fluid and vaginal tissue of HIV-negative women. J Acquir Immune Defic Syndr 51:546-553. http://dx.doi.org/10.1097/QAI.0b013e3181ae69c5.
75. Van Rompay KK, Hamilton M, Kearney B, Bischofberger N. 2005. Pharmacokinetics of tenofovir in breast milk of lactating rhesus macaques. Antimicrob Agents Chemother 49:2093-2094. http://dx.doi.org/10.1128/AAC.49.5.2093-2094.2005.
76. Solas C, Lafeuillade A, Halfon P, Chadapaud S, Hittinger G, Lacarelle B. 2003. Discrepancies between protease inhibitor concentrations and viral load in reservoirs and sanctuary sites in human immunodeficiency virus-infected patients. Antimicrob Agents Chemother 47:238-243. http://dx.doi.org/10.1128/AAC.47.1.238-243.2003.
77. Ferraretto X, Estellat C, Damond F, Longuet P, Epelboin S, Demailly P, Yazbeck C, Llabador MA, Pasquet B, Yazdanpanah Y, Matheron S, Patrat C. 2014. Timing of intermittent seminal HIV-1 RNA shedding in patients with undetectable plasma viral load under combination antiretroviral therapy. PLoS One 9:e88922. http://dx.doi.org/10.1371/journal.pone.0088922.
78. Bujan L, Daudin M, Matsuda T, Righi L, Thauvin L, Berges L, Izopet J, Berrebi A, Massip P, Pasquier C. 2004. Factors of intermittent HIV-1 excretion in semen and efficiency of sperm processing in obtaining spermatozoa without HIV-1 genomes. AIDS 18:757-766. http://dx.doi.org/10.1097/00002030-200403260-00006.
79. Gianella S, Anderson CM, Vargas MV, Richman DD, Little SJ, Morris SR, Smith DM. 2013. Cytomegalovirus DNA in semen and blood is associated with higher levels of proviral HIV DNA. J Infect Dis 207:898-902. http://dx.doi.org/10.1093/infdis/jis777.
80. Gupta P, Leroux C, Patterson BK, Kingsley L, Rinaldo C, Ding M, Chen Y, Kulka K, Buchanan W, McKeon B, Montelaro R. 2000. Human immunodeficiency virus type 1 shedding pattern in semen correlates with the compartmentalization of viral quasi species between blood and semen. J Infect Dis 182:79-87. http://dx.doi.org/10.1086/315644.
81. Bourry O, Mannioui A, Sellier P, Roucairol C, Durand-Gasselin L, Dereuddre-Bosquet N, Benech H, Roques P, Le Grand R. 2010. Effect of a short-term HAART on SIV load in macaque tissues is dependent on time of initiation and antiviral diffusion. Retrovirology 7:78. http://dx.doi.org/10.1186/1742-4690-7-78.
82. Ene L, Duiculescu D, Ruta SM. 2011. How much do antiretroviral drugs penetrate into the central nervous system? J Med Life 4:432-439.
83. Leslie EM, Deeley RG, Cole SP. 2005. Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense. Toxicol Appl Pharmacol 204:216-237. http://dx.doi.org/10.1016/j.taap.2004.10.012.
84. Robillard KR, Hoque T, Bendayan R. 2012. Expression of ATP-binding cassette membrane transporters in rodent and human Sertoli cells: relevance to the permeability of antiretroviral therapy at the blood-testis barrier. J Pharmacol Exp Ther 340:96-108. http://dx.doi.org/10.1124/jpet.111.186916.
85. Le Tortorec A, Dejucq-Rainsford N. 2010. HIV infection of the male genital tract-consequences for sexual transmission and reproduction. Int J Androl 33:e98-e108. http://dx.doi.org/10.1111/j.1365-2605.2009.00973.x.
86. Ganor Y, Zhou Z, Bodo J, Tudor D, Leibowitch J, Mathez D, Schmitt A, Vacher-Lavenu MC, Revol M, Bomsel M. 2013. The adult penile urethra is a novel entry site for HIV-1 that preferentially targets resident urethral macrophages. Mucosal Immunol 6:776-786. http://dx.doi.org/10.1038/mi.2012.116.
87. Pudney J, Anderson D. 2011. Innate and acquired immunity in the human penile urethra. J Reprod Immunol 88:219-227. http://dx.doi.org/10.1016/j.jri.2011.01.006.
88. Pudney J, Anderson DJ. 1995. Immunobiology of the human penile urethra. Am J Pathol 147:155-165.
89. Calantone N, Wu F, Klase Z, Deleage C, Perkins M, Matsuda K, Thompson EA, Ortiz AM, Vinton CL, Ourmanov I, Lore K, Douek DC, Estes JD, Hirsch VM, Brenchley JM. 2014. Tissue myeloid cells in SIV-infected primates acquire viral DNA through phagocytosis of infected T cells. Immunity 41:493-502. http://dx.doi.org/10.1016/j.immuni.2014.08.014.
90. Micci L, Alvarez X, Iriele RI, Ortiz AM, Ryan ES, McGary CS, Deleage C, McAtee BB, He T, Apetrei C, Easley K, Pahwa S, Collman RG, Derdeyn CA, Davenport MP, Estes JD, Silvestri G, Lackner AA, Paiardini M. 2014. CD4 depletion in SIV-infected macaques results in macrophage and microglia infection with rapid turnover of infected cells. PLoS Pathog 10:e1004467. http://dx.doi.org/10.1371/journal.ppat.1004467.
91. Baxter AE, Russell RA, Duncan CJ, Moore MD, Willberg CB, Pablos JL, Finzi A, Kaufmann DE, Ochsenbauer C, Kappes JC, Groot F, Sattentau QJ. 2014. Macrophage infection via selective capture of HIV-1-infected CD4(+) T cells. Cell Host Microbe 16:711-721. http://dx.doi.org/10.1016/j.chom.2014.10.010.
92. Shen R, Richter HE, Clements RH, Novak L, Huff K, Bimczok D, Sankaran-Walters S, Dandekar S, Clapham PR, Smythies LE, Smith PD. 2009. Macrophages in vaginal but not intestinal mucosa are monocyte-like and permissive to human immunodeficiency virus type 1 infection. J Virol 83:3258-3267. http://dx.doi.org/10.1128/JVI.01796-08.
93. Koppensteiner H, Brack-Werner R, Schindler M. 2012. Macrophages and their relevance in human immunodeficiency virus type I infection. Retrovirology 9:82. http://dx.doi.org/10.1186/1742-4690-9-82.
94. Sieweke MH, Allen JE. 2013. Beyond stem cells: self-renewal of differentiated macrophages. Science 342:1242974. http://dx.doi.org/10.1126/science.1242974.
95. Coombs RW, Lockhart D, Ross SO, Deutsch L, Dragavon J, Diem K, Hooton TM, Collier AC, Corey L, Krieger JN. 2006. Lower genitourinary tract sources of seminal HIV. J Acquir Immune Defic Syndr 41:430-438. http://dx.doi.org/10.1097/01.qai.0000209895.82255.08.
96. Ilaria G, Jacobs JL, Polsky B, Koll B, Baron P, MacLow C, Armstrong D, Schlegel PN. 1992. Detection of HIV-1 DNA sequences in preejaculatory fluid. Lancet 340:1469. 0140-6736. http://dx.doi.org/10.1016/0140-6736(92)92658-3.
97. Pudney J, Oneta M, Mayer K, Seage G, III, Anderson D. 1992. Preejaculatory fluid as potential vector for sexual transmission of HIV-1. Lancet 340:1470. http://dx.doi.org/10.1016/0140-6736(92)92659-4.
98. Fieni F, Stone M, Ma ZM, Dutra J, Fritts L, Miller CJ. 2013. Viral RNA levels and env variants in semen and tissues of mature male rhesus macaques infected with SIV by penile inoculation. PLoS One 8:e76367. http://dx.doi.org/10.1371/journal.pone.0076367.
99. Le Tortorec A, Satie AP, Denis H, Rioux-Leclercq N, Havard L, Ruffault A, Jegou B, Dejucq-Rainsford N. 2008. Human prostate supports more efficient replication of HIV-1 R5 than X4 strains ex vivo. Retrovirology 5:119. http://dx.doi.org/10.1186/1742-4690-5-119.
100. Miller CJ, Vogel P, Alexander NJ, Dandekar S, Hendrickx AG, Marx PA. 1994. Pathology and localization of simian immunodeficiency virus in the reproductive tract of chronically infected male rhesus macaques. Lab Invest 70:255-262.
101. Pudney J, Anderson D. 1991. Orchitis and human immunodeficiency virus type 1 infected cells in reproductive tissues from men with the acquired immune deficiency syndrome. Am J Pathol 139:149-160.
102. Vernazza PL, Troiani L, Flepp MJ, Cone RW, Schock J, Roth F, Boggian K, Cohen MS, Fiscus SA, Eron JJ. 2000. Potent antiretroviral treatment of HIV-infection results in suppression of the seminal shedding of HIV. The Swiss HIV Cohort Study. AIDS 14:117-121.
103. Kiessling AA, Fitzgerald LM, Zhang D, Chhay H, Brettler D, Eyre RC, Steinberg J, McGowan K, Byrn RA. 1998. Human immunodeficiency virus in semen arises from a genetically distinct virus reservoir. AIDS Res Hum Retroviruses 14:S33-S41.
104. D'Avolio A, Simiele M, Siccardi M, Baietto L, Sciandra M, Oddone V, Stefani FR, Agati S, Cusato J, Bonora S, Di Perri G. 2011. A HPLC-MS method for the simultaneous quantification of fourteen antiretroviral agents in peripheral blood mononuclear cell of HIV infected patients optimized using medium corpuscular volume evaluation. J Pharm Biomed Anal 54:779-788. http://dx.doi.org/10.1016/j.jpba.2010.10.011.
105. Pruvost A, Negredo E, Theodoro F, Puig J, Levi M, Ayen R, Grassi J, Clotet B. 2009. Pilot pharmacokinetic study of human immunodeficiency virus-infected patients receiving tenofovir disoproxil fumarate (TDF): investigation of systemic and intracellular interactions between TDF and abacavir, lamivudine, or lopinavir-ritonavir. Antimicrob Agents Chemother 53:1937-1943. http://dx.doi.org/10.1128/AAC.01064-08.